Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Tamsulosin hydrochloride is safe and effective for long-term treatment of urinary symptoms in BPH patients.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Men with enlarged prostates often have more severe baldness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early balding may have a higher risk of prostate issues, and surgery for prostate cancer has a slight survival benefit over radiation.

Urinary PSA could be an early marker for enlarged prostate.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.